CBUS Stock Analysis: Buy, Sell, or Hold?
CBUS - Cibus, Inc. Class A Common Stock
$2.13
0.11 (5.45%)
▲
5d:
+51.06%
30d:
+77.5%
90d:
+41.06%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 13, 2026
29d
Get Alerted When CBUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CBUS is 27.5% above its trading range ($1.67). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CBUS is 27.5% above its trading range ($1.67). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CBUS is currently trading at $2.13, which is considered extended relative to its 30-day fair value range of $1.19 to $1.67.
Technical Outlook: Technically, CBUS is in a strong downtrend. Immediate support is located at $1.31, while resistance sits at $2.25. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: CBUS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.67 (+588.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CBUS is in a strong downtrend. Immediate support is located at $1.31, while resistance sits at $2.25. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: CBUS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.67 (+588.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.19 -
$1.67
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+27.5% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.4%)
- BULLISH: Trading 588.6% below Wall St target ($14.67)
- WARNING: Recommendation downgraded due to 27.5% overvaluation
Trading Range Analysis
30-Day Trading Range
$1.19 -
$1.67
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.32
Resistance Level
$2.25
Current Trend
Strong Downtrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.38
Wall Street Target
$14.67
(+588.6%)
Revenue Growth (YoY)
62.6%
Share & Embed Analysis
Last updated: July 14, 2026 6:14 AM ET
Data refreshes hourly during market hours. Next update: 7:14 AM
Data refreshes hourly during market hours. Next update: 7:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 57 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 57 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 62 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 63 BUY |
